AAAAAA

   
Results: 1-16 |
Results: 16
Identification of human ccn2(connective tissue growth factor) promoter polymorphisms
Authors: Blom, IE van Dijk, AJ de Weger, RA Tilanus, MGJ Goldschmeding, R
Citation: Ie. Blom et al., Identification of human ccn2(connective tissue growth factor) promoter polymorphisms, J CL PATH-M, 54(3), 2001, pp. 192-196
Sensitive detection of p53 mutation: Analysis by direct sequencing and multisequence analysis
Authors: Rozemuller, EH Kropveld, A Kreyveld, E Leppers, FGJ Scheidel, KC Slootweg, PJ Tilanus, MGJ
Citation: Eh. Rozemuller et al., Sensitive detection of p53 mutation: Analysis by direct sequencing and multisequence analysis, CANCER DET, 25(2), 2001, pp. 109-116
Polymorphism of human HLA-DRB1 antigens generated by genetic exchange between DR2 (DRB115011) and DR6 (DRB1*1405) alleles: a novel DRB1 allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan
Authors: Wu, S Shiao, YM Lai, CY Lai, SM Chen, SP SIdebottom, DA Hildebrand, WH Tilanus, MGJ Chou, FC Tsai, MF
Citation: S. Wu et al., Polymorphism of human HLA-DRB1 antigens generated by genetic exchange between DR2 (DRB115011) and DR6 (DRB1*1405) alleles: a novel DRB1 allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan, TISSUE ANTI, 57(4), 2001, pp. 384-387
No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation
Authors: Bijlsma, FJ Bruggink, AH Hartman, M Gmelig-Meyling, FHJ Tilanus, MGJ de Jonge, N de Weger, RA
Citation: Fj. Bijlsma et al., No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation, TISSUE ANTI, 57(2), 2001, pp. 151-153
IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors
Authors: Baselmans, PJ Pollabauer, EM van Reijsen, FC Heystek, HC Hren, A Stumptner, P Tilanus, MGJ Vooijs, WC Mudde, GC
Citation: Pj. Baselmans et al., IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors, HUMAN IMMUN, 61(8), 2000, pp. 789-798
The origins of multiple squamous cell carcinomas in the aerodigestive tract
Authors: van Oijen, MGCT vonder Straat, FGJL Tilanus, MGJ Slootweg, PJ
Citation: Mgct. Van Oijen et al., The origins of multiple squamous cell carcinomas in the aerodigestive tract, CANCER, 88(4), 2000, pp. 884-893
Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats
Authors: de Weger, RA Tilanus, MGJ Scheidel, KC van den Tweel, JG Verdonck, LF
Citation: Ra. De Weger et al., Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats, BR J HAEM, 110(3), 2000, pp. 647-653
Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116
Authors: Wijnhoven, BPL Tilanus, MGJ Morris, AG Darnton, SJ Tilanus, HW Dinjens, WNM
Citation: Bpl. Wijnhoven et al., Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116, BR J CANC, 82(9), 2000, pp. 1510-1512
Two new HLA DPB1 alleles identified by sequence-based typing: DPB18201 and DPB1*8301
Authors: Voorter, CEM Tilanus, MGJ van den Berg-Loonen, EM
Citation: Cem. Voorter et al., Two new HLA DPB1 alleles identified by sequence-based typing: DPB18201 and DPB1*8301, TISSUE ANTI, 56(6), 2000, pp. 560-562
DPB18501, a novel DPB1 variant in the US Black population
Authors: Rozemuller, EH van der Zwan, AW Voorter, CEM Tilanus, MGJ
Citation: Eh. Rozemuller et al., DPB18501, a novel DPB1 variant in the US Black population, TISSUE ANTI, 56(3), 2000, pp. 282-284
A novel HLA-A24 (A2420) allele identified in the Atayal tribe of Taiwan
Authors: Scheltinga, SA Lai, SM van der Zwan, AW Tilanus, MGJ Wu, S
Citation: Sa. Scheltinga et al., A novel HLA-A24 (A2420) allele identified in the Atayal tribe of Taiwan, TISSUE ANTI, 55(1), 2000, pp. 65-67
p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases
Authors: Tjebbes, GWA Van der Straat, FGJL Tilanus, MGJ Hordijk, GJ Slootweg, PJ
Citation: Gwa. Tjebbes et al., p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases, ORAL ONCOL, 35(4), 1999, pp. 384-389
Sequencing-based typing of MICA reveals 33 alleles: a study on linkage with classical HLA genes
Authors: Visser, CJT Tilanus, MGJ Tatari, Z van der Zwan, AW Bakker, R Rozemuller, EH Schaeffer, V Tamouza, R Charron, D
Citation: Cjt. Visser et al., Sequencing-based typing of MICA reveals 33 alleles: a study on linkage with classical HLA genes, IMMUNOGENET, 49(6), 1999, pp. 561-566
Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers
Authors: Kropveld, A Rozemuller, EH Leppers, FGJ Scheidel, KC de Weger, RA Koole, R Hordijk, GJ Slootweg, PJ Tilanus, MGJ
Citation: A. Kropveld et al., Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers, LAB INV, 79(3), 1999, pp. 347-353
Characterization of a novel HLA-A2 variant, A02012, in the Southern Thai-Muslin population
Authors: Scheltinga, SA van der Zwan, AW Mongkolsuk, T Sujirachato, K Chiewsilp, P Tilanus, MGJ
Citation: Sa. Scheltinga et al., Characterization of a novel HLA-A2 variant, A02012, in the Southern Thai-Muslin population, TISSUE ANTI, 53(5), 1999, pp. 507-509
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor Tcells
Authors: Verdonck, LF Petersen, EJ Lokhorst, HM Nieuwenhuis, HK Dekker, AW Tilanus, MGJ de Weger, RA
Citation: Lf. Verdonck et al., Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor Tcells, BONE MAR TR, 22(11), 1998, pp. 1057-1063
Risultati: 1-16 |